Cancer · 2001 · 45 citations · 26 references
MedicineImmunologyOncologyCancer ImmunologyNeoplasiaTumor ImmunologyBladder CancerMalignant NeoplasmsNeuro-oncologic PathologyTumor AntigensAutoimmune Paraneoplastic SyndromesBladder PathologyOpsoclonus-myoclonus SyndromeParaneoplastic Neurologic SyndromesParaneoplastic Neurological SyndromesPostmortem DiagnosticsTissue Autoantibodies
BACKGROUND: There are several case reports describing paraneoplastic syndromes in patients with various forms of bladder carcinoma. Current immunologic analyses have enabled the identification of the antineuronal autoantibodies associated with specific syndromes. METHODS: A patient with a history of bladder carcinoma presented with opsoclonus and myoclonus. RESULTS: Workup confirmed the presence of anti-Ri antibodies in the patient's serum and cerebrospinal fluid. The target Ri antigen was found to be expressed by the tumor. CONCLUSIONS: To the authors' knowledge, there are few reports in the literature describing the long-term clinical follow-up and postmortem evaluation in a patient with this form of paraneoplastic syndrome. More important, the authors believe the current study represents the first time that the presence of anti-Ri antibodies has been noted in a paraneoplastic syndrome associated with transitional cell carcinoma of the bladder.
26
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Giorgio Cattoretti, Stefano Pileri, Carlo Parravicini et al. · The Journal of Pathology · 1993 · 728 citations
Medicine, Immunology, Pathology +11
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
Francisco A. Luque, R Ferziger, Marc K. Rosenblum et al. · Annals of Neurology · 1991 · 405 citations